Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

Core Viewpoint - Inspire Medical Systems, Inc. will announce its financial results for Q4 and full year 2025 on February 11, 2026, after market close, followed by a conference call to discuss these results and recent business developments [1]. Financial Results Announcement - The financial results will be released after the close of trading on February 11, 2026 [1]. - A conference call will take place at 5:00 p.m. Eastern Time to discuss the results [1]. Conference Call Access - A webcast of the conference call will be available on the Investor Relations page of Inspire's website [2]. - For those wishing to ask questions, registration is required to receive dial-in details and a unique access code [3]. - The company recommends registering at least 10 minutes before the call starts to ensure connection [3]. Replay Availability - A replay of the conference call will be accessible on the Investor Relations website approximately two hours after the event and will be archived for two weeks [4]. Company Overview - Inspire Medical Systems focuses on developing and commercializing innovative, minimally invasive solutions for obstructive sleep apnea [5]. - The company's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea [5].